| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.64B | 11.29B | 12.02B | 8.34B | 10.86B | 11.96B |
| Gross Profit | 12.13B | 10.99B | 11.79B | 8.14B | 10.77B | 11.84B |
| EBITDA | 3.37B | 912.00M | 1.29B | -1.69B | 568.00M | 1.10B |
| Net Income | 2.84B | 2.65B | 1.30B | -2.96B | 875.00M | 937.00M |
Balance Sheet | ||||||
| Total Assets | 71.93B | 69.39B | 80.75B | 66.19B | 80.37B | 87.17B |
| Cash, Cash Equivalents and Short-Term Investments | 23.61B | 22.46B | 25.63B | 24.17B | 29.33B | 34.20B |
| Total Debt | 13.74B | 11.36B | 10.01B | 10.25B | 15.76B | 17.21B |
| Total Liabilities | 45.33B | 39.26B | 41.35B | 31.99B | 41.94B | 48.58B |
| Stockholders Equity | 26.60B | 30.12B | 39.40B | 34.20B | 38.44B | 38.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 518.00M | 2.95B | -2.89B | -6.73B | 1.92B |
| Operating Cash Flow | 0.00 | 853.00M | 3.49B | -2.58B | -4.07B | 2.06B |
| Investing Cash Flow | 0.00 | 2.29B | 1.51B | 78.00M | 70.00M | 516.00M |
| Financing Cash Flow | 0.00 | -5.46B | -2.10B | -4.65B | -495.00M | 7.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥88.32B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
80 Outperform | ¥192.71B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
74 Outperform | ¥258.60B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
71 Outperform | ¥71.50B | 12.60 | 9.22% | 6.15% | 7.45% | 45.25% | |
68 Neutral | ¥52.64B | 9.12 | ― | 4.86% | 6.40% | 41.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥46.97B | 10.12 | ― | 4.36% | 1.14% | -16.88% |